You're viewing a public preview of 4basebio PLC Sign up free to access full investment history, financials, executives & more

4basebio PLC

(DBA 4basebio) (formerly Expedeon AG (Sygnis AG) (SYGNIS Pharma AG)) Active
25 Norman Way Over,  Cambridge,  CB24 5QE,  United Kingdom
+44 1223 967 943
Sector: Life Science Entity: Private Employees: 21
1
M&A Activity
Sign up to view
About 4basebio PLC
Within the Acquity Data private market database, 4basebio PLC operates in the Life Science sector. Corporate transaction records indicate 1 M&A transaction associated with the company. The company is headquartered in Cambridge. This profile is documented within Acquity Data.
4basebio PLC M&A Activity
1 Acquisition
# Company Transaction Date Close Date Sector Country
View 1 M&A Acquisition
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does 4basebio PLC do?
Within the Acquity Data private market database, 4basebio PLC operates in the Life Science sector. Corporate transaction records indicate 1 M&A transaction associated with the company. The company is headquartered in Cambridge. This profile is documented within Acquity Data.
Where is 4basebio PLC headquartered?
4basebio PLC is headquartered in Cambridge, United Kingdom.
When was 4basebio PLC founded?
Founded year information for 4basebio PLC is available on AcquityData.
What sector is 4basebio PLC in?
4basebio PLC operates in the Life Science sector.
Who are the investors in 4basebio PLC?
Investor information for 4basebio PLC is available to AcquityData members. Sign up for free to access full ownership history.
How many M&A transactions has 4basebio PLC been involved in?
Transaction data for 4basebio PLC is available to AcquityData members.

Unlock the full 4basebio PLC profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access 4basebio PLC's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial